 Proactive Investors Australia | Living Cell Technologies NTCELL implant shows fast improvement of Parkinson's ... Proactive Investors Australia The patent will be assigned to Diatranz Otsuka, a joint venture company established by Living Cell Technologies and Otsuka Pharmaceutical Factory, to commercialise xenotransplantation for the treatment of Type 1 diabetes. The Company is a publisher and ... LCT Granted E.U. Patent for Tissue Engineering |
